Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Tomohiro Yabushita und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Azacitidine, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Uehara Memorial Foundation, Core Research for Evolutional Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
- Division of Cancer Cell Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; The Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan.
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
- Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan; Department of Pediatrics, Graduate School of Medicin…
Förderung
- Japan Agency for Medical Research and Development
- Uehara Memorial Foundation
- Core Research for Evolutional Science and Technology
- Kanae Foundation for the Promotion of Medical Science
- Japan Society for the Promotion of Science
Zitieren
APA
Yabushita, T., Chinen, T., Nishiyama, A., Asada, S., Shimura, R., Isobe, T., Yamamoto, K., Sato, N., Enomoto, Y., Tanaka, Y., Fukuyama, T., Satoh, H., Kato, K., Saitoh, K., Ishikawa, T., Soga, T., Nannya, Y., Fukagawa, T., Nakanishi, M., …, & Goyama, S. (2023). Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113098
Vancouver
Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, et al. Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113098
BibTeX
@article{Yabushita2023,
author = {Yabushita, Tomohiro and Chinen, Takumi and Nishiyama, Atsuya and Asada, Shuhei and Shimura, Ruka and Isobe, Tomoya and Yamamoto, Keita and Sato, Naru and Enomoto, Yutaka and Tanaka, Yosuke and Fukuyama, Tomofusa and Satoh, Hitoshi and Kato, Keiko and Saitoh, Kaori and Ishikawa, Takamasa and Soga, Tomoyoshi and Nannya, Yasuhito and Fukagawa, Tatsuo and Nakanishi, Makoto and Kitagawa, Daiju and Kitamura, Toshio and Goyama, Susumu},
title = {Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113098}
}
EUVIMED